Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations


Por: Barranco-Altirriba, M, Granado-Casas, M, Yanes, O, Capellades, J, Junza, A, Franch-Nadal, J, Vendrell, J, Llaurado, G, Valdés, S, García-Escobar, E, Bermúdez-Lopez, M, Valdivielso, JM, Lopez-Lifante, VM, Herrero-Alonso, C, Falguera, M, Vilanova, MB, Arteaga, I, Torán-Monserrat, P, Perera-Lluna, A, Castelblanco, E, Mauricio, D

Publicada: 3 dic 2025
Resumen:
Background Type 2 diabetes (T2D) is increasing its burden worldwide; therefore, research focused on its prediction and prevention is essential.Methods We performed an untargeted metabolomics analysis using ultra high-performance liquid chromatography-mass spectrometry to discover metabolic biomarkers and biological pathways associated with incident T2D with a nested case-control design, followed by validation with targeted metabolomics in an independent cohort. In the discovery phase, plasma samples from 352 subjects (209 controls and 143 incident cases) were analyzed, collected with a mean (standard deviation) of 7.40 (0.76) years before they acquired the condition. Using this discovery phase cohort, six metabolites were identified using standards and were subsequently quantified in an independent validation phase cohort of 2,044 subjects (167 incident cases). Additionally, pathway enrichment was conducted in the discovery cohort.Results Guanine, ecgonine, adenine, pregnenolone sulfate, phenyl sulfate, and citrulline were significantly associated with incident T2D in at least one of the analyses performed in the discovery phase. Among these, guanine, pregnenolone sulfate, and citrulline maintained their significant associations with incident T2D in the validation cohort. Additionally, several pathways were significantly altered, with nucleotide metabolism and ABC transporter pathways among the most consistently affected.Conclusion We identified significant associations of guanine, pregnenolone sulfate, and citrulline with incident T2D.

Filiaciones:
Barranco-Altirriba, M:
 Hosp Santa Creu I St Pau, Dept Endocrinol & Nutr, Barcelona, Spain

 Univ Politecn Cataluna, Inst Recerca & Innovacio Salut IRIS, Bioinformat & Biomed Signals Lab B2SLab, Barcelona, Spain

 Networking Biomed Res Ctr Subject Area Bioengn Bio, Madrid, Spain

 Inst Recerca St Joan de Deu, Esplugas de Llobregat, Barcelona, Spain

Granado-Casas, M:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Inst Univ Invest Atencio Primaria Jordi Gol, Res Support Unit, DAP Cat Grp, Barcelona, Spain

 Univ Lleida, Fac Nursing & Physiotherapy, Dept Nursing & Physiotherapy, GESEC Grp, Lleida, Spain

 Inst Biomed Res Lleida IRBLleida, Healthcare Res Grp GRECS, Lleida, Spain

Yanes, O:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Univ Rovira i Virgili, Inst Hlth Res Pere Virgili, Dept Elect Engn, Tarragona, Spain

Capellades, J:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Inst Hlth Res Pere Virgili IISPV, Tarragona, Spain

Junza, A:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Univ Rovira i Virgili, Sci & Tech Resources Serv, Tarragona, Spain

Franch-Nadal, J:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Inst Univ Invest Atencio Primaria Jordi Gol, Res Support Unit, DAP Cat Grp, Barcelona, Spain

Vendrell, J:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Univ Rovira i Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili IISPV, Dept Endocrinol & Nutr,Res Unit, Tarragona, Spain

Llaurado, G:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Hosp del Mar, Med Res Inst IMIM, Dept Endocrinol & Nutr, Barcelona, Spain

Valdés, S:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Hosp Reg Univ Malaga, UGC Endocrinol & Nutr, IBIMA Plataforma BIONAND, Malaga, Spain

García-Escobar, E:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Hosp Reg Univ Malaga, UGC Endocrinol & Nutr, IBIMA Plataforma BIONAND, Malaga, Spain

Bermúdez-Lopez, M:
 Univ Lleida, Expt Med Dept, Lleida, Spain

 Inst Recerca Biomed IRBLleida, Vasc & Renal Translat Res Grp, Lleida, Spain

Valdivielso, JM:
 Inst Recerca Biomed IRBLleida, Vasc & Renal Translat Res Grp, Lleida, Spain

Lopez-Lifante, VM:
 Univ Autonoma Barcelona, Fac Med, Bellaterra, Spain

 Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain

 Inst Catala Salut, Primary Healthcare Palau Solita & Plegamans, Gerencia Ambit Atencio Primaria Metropolitana Nord, Barcelona, Spain

Herrero-Alonso, C:
 Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain

Falguera, M:
 Inst Univ Invest Atencio Primaria Jordi Gol, Res Support Unit, DAP Cat Grp, Barcelona, Spain

 Univ Lleida, Dr Pifarre Fdn IRB Lleida, Inst Biomed Res, Lleida, Spain

 Inst Catala Salut, Primary Hlth Care Ctr Tarrega, Gerencia Atencio Primaria, Barcelona, Spain

Vilanova, MB:
 Inst Univ Invest Atencio Primaria Jordi Gol, Res Support Unit, DAP Cat Grp, Barcelona, Spain

 Consorci Sanitari Anoia, Primary Hlth Care Ctr Igualada Nord, Igualada, Spain

Arteaga, I:
 Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain

 Inst Catala Salut, Primary Healthcare Ctr Vall del Tenes, Gerencia Ambit Atencio Primaria Metropolitana Nord, Barcelona, Spain

Torán-Monserrat, P:
 Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain

 Univ Girona, Fac Med, Dept Med, Girona, Spain

 Inst Univ Invest Atencio Primaria Jordi Gol IDIAPJ, Multidisciplinary Res Grp Hlth & Soc GREMSAS, Barcelona, Spain

Perera-Lluna, A:
 Univ Politecn Cataluna, Inst Recerca & Innovacio Salut IRIS, Bioinformat & Biomed Signals Lab B2SLab, Barcelona, Spain

 Networking Biomed Res Ctr Subject Area Bioengn Bio, Madrid, Spain

 Inst Recerca St Joan de Deu, Esplugas de Llobregat, Barcelona, Spain

Castelblanco, E:
 Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA

Mauricio, D:
 Hosp Santa Creu I St Pau, Dept Endocrinol & Nutr, Barcelona, Spain

 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red CIBER Diabet & Associated Me, Barcelona, Spain

 Inst Invest Biomed St Pau IR St Pau, Barcelona, Spain

 Cent Univ Catalonia, Univ Vic, Fac Med, Vic, Spain
ISSN: 16642392





Frontiers in Endocrinology
Editorial
FRONTIERS MEDIA SA, AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 16 Número:
Páginas:
WOS Id: 001639788900001
ID de PubMed: 41416067
imagen Green Submitted, gold

MÉTRICAS